Growth hormone secretagogues: recent advances and applications
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 4 (11) , 497-506
- https://doi.org/10.1016/s1359-6446(99)01415-4
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Novel Orally Active Growth Hormone SecretagoguesJournal of Medicinal Chemistry, 1998
- Growth Hormone Status during Long-Term Hexarelin TherapyJournal of Clinical Endocrinology & Metabolism, 1998
- Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood PressureJournal of Clinical Endocrinology & Metabolism, 1997
- Plasma growth hormone response to growth hormone‐releasing hexapeptide (GH‐RP‐6) in children with short statureActa Paediatrica, 1995
- Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in ratsLife Sciences, 1995
- Short Term Effect of Intranasal Administration of Hexarelin — A Synthetic Growth Hormone-Releasing Peptide. Preliminary CommunicationJournal of Pediatric Endocrinology and Metabolism, 1995
- GH Releasing Peptides - Structure and KineticsJournal of Pediatric Endocrinology and Metabolism, 1993
- Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP‐6Clinical Endocrinology, 1993
- Growth Hormone-Releasing Peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranesLife Sciences, 1992
- Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormoneJournal of Clinical Endocrinology & Metabolism, 1992